Glutathione Dosage: How Much Is Actually Used, by Route

12 min readWritten by Protocol Health Editorial TeamMedically reviewed by Richard Dentico, MDPublished Updated

Glutathione dosage depends on the route, and there is no established universal dose. Oral glutathione trials have used 250–1,000 mg per day, and a liposomal pilot used 500–1,000 mg per day. Injectable and IV glutathione are compounded, not FDA-approved, prescription-only and dosed by a clinician; the best-documented IV regimen, from a small Parkinson's trial, was 1,400 mg three times a week. No amount of glutathione has been shown to safely lighten skin.

Glutathione Dosage: How Much Is Actually Used, by Route
Here’s what we’ll cover

Key takeaways

The short answer

How much glutathione do people actually take?

People take widely different amounts of glutathione, because there is no single established dose. A 2014 overview of glutathione in Integrative Medicine notes that it can be given orally, intravenously, inhaled or intranasally, that IV glutathione has a short half-life, and that whether plain oral glutathione raises cellular levels is still debated. Injectable forms are prepared by compounding pharmacies, a category the FDA describes as not FDA-approved. Unlike a vitamin with a recommended daily allowance, glutathione has no RDA, no FDA-approved dosing for general wellness, and no consensus guideline. What exists instead is a range of doses used in published studies and in clinical practice.

Published oral trials have used 250 to 1,000 mg per day. The largest is a six-month randomized, placebo-controlled trial that gave 54 healthy non-smoking adults 250 mg or 1,000 mg daily. Body glutathione stores rose at both doses: blood levels rose 17% at the low dose, and red-cell, plasma and lymphocyte levels rose 30–35% at the high dose (Richie et al., 2015).

Injectable and intravenous glutathione are a different category entirely. They are prescription-only, prepared by a compounding pharmacy that is not FDA-approved, and dosed by the prescribing clinician. No dose-finding study exists for injectable glutathione, so we do not publish a clinic range as if it were one. Protocol Health offers glutathione therapy, so we have a commercial interest in it. For what glutathione is, see what is glutathione.

Dosage by route

Glutathione dosage by route of administration

Glutathione dosage depends on the route of administration more than on almost anything else. Oral glutathione absorption is limited and slow, not zero: a single 3 g dose did not raise blood glutathione over four and a half hours (Witschi et al., 1992), but daily doses raised body stores over months (Richie et al., 2015). An IV enters the bloodstream directly, though IV glutathione has a short half-life. A subcutaneous or intramuscular injection is absorbed from under the skin or from muscle. Both injectable routes avoid gut breakdown, but we found no human trial showing that injection raises glutathione inside cells more than oral glutathione. Oral and injectable doses therefore cannot be converted into one another.

RouteDose used in published researchSourcePrescription?
Oral (standard)250 or 1,000 mg/day for 6 monthsRichie 2015, randomized trial (54 adults)No
Liposomal500 or 1,000 mg/day for 1 monthSinha 2018, pilot (12 adults)No
Intramuscular or subcutaneousNo dose-finding study; set by the prescriberNoneYes (compounded)
Intravenous1,400 mg three times weekly for 4 weeksHauser 2009, Parkinson's pilot (21 patients)Yes (compounded)
Doses used in published studies. Not a dosing recommendation; injectable and IV glutathione are compounded, prescribed and administered by a clinician.

In short, the route of administration decides the dose, and oral and injectable doses are not interchangeable.

Maximum dosage per day

What is the maximum dosage of glutathione per day?

The maximum dosage of glutathione per day has not been established: we found no guideline or regulator limit and no trial designed to find one. The highest daily oral dose in the six-month randomized trial, in 54 healthy adults, was 1,000 mg (Richie et al., 2015), and the liposomal pilot's top dose was 1,000 mg per day for one month (Sinha et al., 2018). Those are the doses researchers chose to test, not safe ceilings, and a supplement maker funded the liposomal study.

For injectable glutathione, any maximum is the prescriber's call. One IV schedule with trial data, 1,400 mg three times a week for four weeks, came from a small Parkinson's pilot (21 patients) that did not show a symptom benefit over placebo (Hauser et al., 2009). That was an intravenous regimen; it does not describe subcutaneous or intramuscular glutathione, and no trial has set a dose for those. It was a trial regimen, not a limit and not a target.

More glutathione is not automatically better. A higher blood level is not the same as a benefit: the Parkinson's IV pilot showed no significant symptom difference. The risks of injectables come from sterility, ingredient quality and dilution as much as from the number. The FDA's 2026 warning about supplement-grade glutathione in compounded injectables is covered below (FDA, 2026).

Oral glutathione

Oral glutathione dosage

250–1,000 mg per day is the range used in the main oral glutathione trial.

What the research used

The six-month trial (Richie et al., 2015) used 250 mg and 1,000 mg daily. Blood glutathione was higher at 1, 3 and 6 months at both doses, the increases were mostly larger at the higher dose and over time, and levels returned to baseline within a month of stopping (Richie et al., 2015).

The absorption problem

The absorption problem is that oral glutathione is broken down by intestinal and hepatic gamma-glutamyltransferase, so the body must rebuild it from its amino acids. That is why a single 3 g dose did not raise blood glutathione (Witschi et al., 1992). Daily dosing over months did raise body stores, so oral absorption is limited and slow, not zero.

Liposomal glutathione

Liposomal and sublingual glutathione dosage

The only published liposomal or sublingual glutathione dosage is 500–1,000 mg per day, used in one liposomal pilot.

Liposomal and sublingual forms are marketed on better absorption than standard oral glutathione, which is largely broken down in the gut. In a one-month pilot of 12 healthy adults, liposomal glutathione at 500 or 1,000 mg a day raised blood glutathione within one to two weeks (Sinha et al., 2018). A supplement maker funded that study, and it did not compare liposomal with standard oral glutathione head to head.

The evidence base is thinner than the marketing implies: the only liposomal study was a 12-person, one-month pilot.

Injection and IV

Injectable and IV glutathione dosage

Injectable and IV glutathione dosage is set by a prescriber, because injectable glutathione is prescription-only in the United States and is not an FDA-approved drug. It is prepared by compounding pharmacies, which means FDA does not verify its safety, effectiveness or quality; it has not gone through FDA review for safety, effectiveness or manufacturing quality.

Ranges used clinically

The ranges used clinically for intramuscular or subcutaneous glutathione are set by the prescribing clinician, because no published trial has set a dose. IV glutathione reaches high blood levels quickly but does not stay there: after a large infusion in 10 healthy volunteers, plasma glutathione fell with a half-life of about 14 minutes (Aebi et al., 1991).

The best-documented IV regimen comes from Parkinson's disease. A randomized pilot gave 1,400 mg three times a week for four weeks; it was well tolerated but did not significantly improve symptom scores compared with placebo (Hauser et al., 2009). Glutathione is not an approved treatment for Parkinson's.

IV glutathione also carries a current quality warning. In August 2026 the FDA reported at least 30 patients with adverse events, including fever, chills, sepsis-like symptoms and hospitalizations, after IV glutathione that compounding pharmacies had made from one lot of dietary-supplement-grade glutathione (FDA, 2026). The FDA says supplement-grade ingredients should not be used in injectable drugs, so it is reasonable to ask any clinic where its compounded glutathione comes from.

Why these are not self-administered

These are not self-administered because dose, dilution, infusion rate and sterility all matter, as the 2026 endotoxin reports show, and none of them are things a label can manage for you. A clinician sets the dose against your indication, weight, labs and medication list, and adjusts it based on response.

NAC as an alternative

Does NAC raise glutathione?

NAC does raise glutathione, but indirectly: it is a glutathione precursor, not glutathione.

NAC supplies cysteine, the rate-limiting building block for new glutathione. In a small study of older adults with low glutathione, two weeks of cysteine and glycine supplements raised red-cell glutathione to the level seen in younger adults (Sekhar et al., 2011). NAC dosing is set by the clinician or the product label; it is not interchangeable with a glutathione dose.

It also has a long clinical track record: NAC is FDA-approved as the antidote for acetaminophen overdose. Our post on NAD+ benefits covers another precursor-based approach.

What changes your dose

What determines glutathione dosage?

Glutathione dosage is determined mainly by route.

Beyond route, the dose depends on why you are taking it, your body size and baseline status, other medications and your response over time.

  • Route. The single biggest factor. Oral and IV doses are not interchangeable, since oral glutathione is largely broken down before absorption.
  • Why you are taking it. General antioxidant support, oxidative stress on labs, and adjunct use alongside another therapy are not the same clinical question. Our longevity lab panel post covers what labs can show.
  • Body size and baseline status. Starting glutathione levels vary. In one small study, older adults had about half the red-cell glutathione of younger adults (Sekhar et al., 2011).
  • Other medications. Glutathione and NAC should both be reviewed against your full medication list by a clinician.
  • Response over time. A dose that is right at week one is not automatically right at week twelve.

Protocol Health's glutathione therapy is part of a plan built on labs and medical history rather than a standing product at a fixed dose. If injectable glutathione is appropriate, the dose is set and adjusted by the prescribing clinician.

Glutathione protocol

What is a glutathione protocol?

A glutathione protocol is a prescriber's written plan for route, dose, schedule, monitoring and stop points, and there is no standard published protocol for injectable glutathione. The only schedules with trial data are narrow: oral glutathione daily for six months (Richie et al., 2015) and IV glutathione three times a week for four weeks in Parkinson's disease (21 patients) (Hauser et al., 2009). Neither tests a wellness protocol.

  • Starting point. A review of your medical history, medications, allergies and any labs.
  • Route and product. Oral, liposomal or injectable, whichever applies, with the pharmacy and ingredient source confirmed; see pharmaceutical-grade vs research-grade for why sourcing matters.
  • Schedule. Set by the prescriber, not copied from a trial or another patient.
  • Monitoring. Check-ins on side effects and response, with a plan for when to stop.

A protocol that promises a fixed result or a fixed number for everyone is a marketing claim, not clinical evidence.

Safety

Is glutathione safe at these doses?

Glutathione is not proven safe at every dose, but no serious harm was reported in the published oral trials we reviewed, and IV glutathione was well tolerated in the Parkinson's pilot.

Injectable and IV glutathione carry the risks of any injection or infusion, including infection if sterile technique fails. Because compounded products are not FDA-reviewed, quality depends heavily on the pharmacy; contaminated lots caused sepsis-like symptoms and hospitalizations. See our safety information.

People with asthma should be cautious: in a small trial, inhaled (nebulized) glutathione caused marked airway narrowing in people with mild asthma (Marrades et al., 1997).

In short: oral trials used 250–1,000 mg a day, injectable and IV doses are set by the prescriber because no dose-finding study exists, and no dose is proven to lighten skin. For other injectables, see our vitamin B12 injections and peptide therapy guide.

At Protocol Health

Glutathione dosage at Protocol Health

Glutathione dosage at Protocol Health is set by a clinician after a review, never from a chart. Protocol Health offers glutathione therapy, so we have a commercial interest in it. Our injectable glutathione is compounded and not FDA-approved, which means it has not been through FDA review for safety, effectiveness or manufacturing quality, and it is not offered for skin lightening.

If you want to know whether it fits your history and medications, start the quiz and a clinician will review your answers. Not everyone is a candidate, and declining to prescribe is a normal outcome.

Bottom Line

The Bottom Line

Glutathione dosage has no official standard, only doses tested in a few small studies.

FAQ

Frequently Asked Questions

How much glutathione should I take per day?

No established daily dose of glutathione exists; the right amount is a decision for you and a clinician. Oral trials have used 250 to 1,000 mg daily, and a liposomal pilot used 500 to 1,000 mg daily. Injectable or IV glutathione is compounded, prescription-only and dosed by a clinician.

What is the dosage for glutathione injections?

No published trial has set a dose for glutathione injections, so the prescribing clinician sets it. The best-documented IV regimen is 1,400 mg three times weekly for four weeks, from a small Parkinson's trial. Injectable glutathione is compounded and not FDA-approved.

Can you take too much glutathione?

Yes, too much glutathione is possible in practice mainly with injectables. A single 3 g oral dose did not raise blood levels. With injectable and IV glutathione, sterility and ingredient quality matter: in 2026 the FDA linked supplement-grade glutathione in compounded IV products to fever, sepsis-like symptoms and hospitalizations.

How long does it take glutathione to work?

Glutathione takes about a month to raise blood levels orally: in the six-month trial, levels were higher at one month and rose further by six. IV glutathione raises blood levels immediately but falls back with a plasma half-life of about 14 minutes. A blood level change is not the same as feeling different.

Is IV glutathione better than oral?

IV glutathione is not proven better than oral. IV raises blood levels far more but only briefly, with a 14-minute half-life, while daily oral glutathione raised body stores over months. We found no human trial showing IV or injection raises glutathione inside cells more than oral.

Does glutathione lighten skin?

Glutathione's skin-lightening evidence is weak. A 2018 review found the IV evidence rested on one flawed study, and a 2016 review notes the Philippines' FDA warned against IV glutathione for skin lightening. Protocol Health does not offer glutathione for that purpose.

What is the maximum dosage of glutathione per day?

No official maximum dosage of glutathione per day has been established. The highest daily oral dose in the six-month randomized trial was 1,000 mg, and a prescriber sets any injectable dose. Trial doses are not safe ceilings or targets.

Should I take glutathione or NAC?

Whether to take glutathione or NAC depends on your labs and medications. NAC supplies cysteine, and supplemental NAC is effective at raising glutathione levels, per a 2014 review. In older adults, cysteine and glycine restored glutathione. Ask a clinician rather than a supplement label.

Explore

Related at Protocol Health

Ask a clinician what dose makes sense for you

Medical disclaimer

This article is for education only and is not medical advice, diagnosis, or treatment. Talk to a licensed clinician before starting, stopping, or changing any medication.

Important safety information

References

  1. Pizzorno J, 2014. Glutathione! Integr Med (Encinitas). PMID 26770075. https://pmc.ncbi.nlm.nih.gov/articles/PMC4684116/
  2. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  3. Richie JP Jr et al., 2015. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. PMID 24791752. https://pubmed.ncbi.nlm.nih.gov/24791752/
  4. Witschi A et al., 1992. The systemic availability of oral glutathione. Eur J Clin Pharmacol. PMID 1362956. https://pubmed.ncbi.nlm.nih.gov/1362956/
  5. Sinha R et al., 2018. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr. PMID 28853742. https://pubmed.ncbi.nlm.nih.gov/28853742/
  6. Hauser RA et al., 2009. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease. Mov Disord. PMID 19230029. https://pubmed.ncbi.nlm.nih.gov/19230029/
  7. U.S. Food and Drug Administration, 2026. FDA reminds compounders not to use dietary supplement grade glutathione for injectables. https://www.fda.gov/drugs/human-drug-compounding/fda-reminds-compounders-not-use-dietary-supplement-grade-glutathione-injectables
  8. Aebi S et al., 1991. High-dose intravenous glutathione in man. Eur J Clin Invest. PMID 1907548. https://pubmed.ncbi.nlm.nih.gov/1907548/
  9. Sonthalia S et al., 2018. Glutathione for skin lightening: a regnant myth or evidence-based verity? Dermatol Pract Concept. PMID 29445569. https://pubmed.ncbi.nlm.nih.gov/29445569/
  10. Sonthalia S et al., 2016. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies. Indian J Dermatol Venereol Leprol. PMID 27088927. https://pubmed.ncbi.nlm.nih.gov/27088927/
Show all 13 references
  1. Sekhar RV et al., 2011. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. PMID 21795440. https://pubmed.ncbi.nlm.nih.gov/21795440/
  2. Ershad M et al., 2024. N-Acetylcysteine. StatPearls. PMID 30725868. https://pubmed.ncbi.nlm.nih.gov/30725868/
  3. Marrades RM et al., 1997. Nebulized glutathione induces bronchoconstriction in patients with mild asthma. Am J Respir Crit Care Med. PMID 9279219. https://pubmed.ncbi.nlm.nih.gov/9279219/

Why trust our physicians

Every article is reviewed by a licensed physician on our medical team and is kept current by our editorial team. Read our editorial policy and our medical review process.

Medically reviewed by
Richard Dentico, MD on
Written by
Protocol Health Editorial Team
First published
Last updated

See an error? Email care@protocolhealthmd.com and we will review it.

More on Glutathione

All Nutrition articles →